Avadel Pharmaceuticals (AVDL) Leases (2017 - 2022)
Historic Leases for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Q3 2022 value amounting to $1.9 million.
- Avadel Pharmaceuticals' Leases fell 594.2% to $1.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.9 million, marking a year-over-year decrease of 594.2%. This contributed to the annual value of $2.7 million for FY2021, which is 184.33% up from last year.
- As of Q3 2022, Avadel Pharmaceuticals' Leases stood at $1.9 million, which was down 594.2% from $2.2 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Leases registered a high of $6.0 million during Q3 2018, and its lowest value of $1.9 million during Q3 2022.
- Moreover, its 5-year median value for Leases was $3.0 million (2020), whereas its average is $3.5 million.
- In the last 5 years, Avadel Pharmaceuticals' Leases skyrocketed by 7346.17% in 2018 and then plummeted by 4284.93% in 2020.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Leases stood at $5.0 million in 2018, then decreased by 28.42% to $3.6 million in 2019, then fell by 27.91% to $2.6 million in 2020, then increased by 1.84% to $2.7 million in 2021, then dropped by 26.58% to $1.9 million in 2022.
- Its last three reported values are $1.9 million in Q3 2022, $2.2 million for Q2 2022, and $2.4 million during Q1 2022.